Zhu et al. [81] found that miR-652-3p can directly regulate KCNN3 to promote the proliferation, migration, and invasion of bladder cancer cells, and it is likely to be a potential target for bladder cancer treatment. This evidence concerns the gene KCNN3 and urinary bladder cancer.